MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202621106999 A) filed by Mayons Pharmaceuticals Private Limited on September 05, 2026, for “an Anti-Osteoarthritic Formulation And Method Of Preparation Thereof”.
Inventors include Yusuf Hamza Chimthanawala; and Nasreen Y. Chimthanawala.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: ABSTRACT AN ANTI-OSTEOARTHRITIC FORMULATION AND METHOD OF PREPARATION THEREOF The present invention relates to the field of pharmaceutical formulation. In particular, the invention relates to a stable anti-osteoarthritic formulation tablet comprising Cissus quadrangularis extract, Boswellia serrata extract, Rhus tox extract, Rhododendron chrysanthum extract, Guaiacum officinale extract and Berberis vulgaris extract, in combination with pharmaceutically acceptable inert excipients for the management of Osteoarthritis. The invention also provides a method for preparing the same.
Disclaimer: Curated by HT Syndication.
